COMMUNIQUÉS West-GlobeNewswire

Mapi Pharma is Seeking New Depot Product Partnerships
02/12/2024
Management to Participate in 7th Annual Evercore HealthCONx Conference NESS ZIONA, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical [...]
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
02/12/2024
Healthy Extracts expands order after high demand for Gelteq’s collagen and Mynus sugar blocker gels NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and [...]
OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development
02/12/2024
MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform [...]
NovelMed Receives FDA IND Approval for NM8074 (Ruxoprubart), the First Anti-Bb Alternative Pathway Blocker for Treating Primary Immunoglobulin A Nephropathy (IgAN): A Renal Disorder
02/12/2024
--- The United States FDA Clears Initiation of a Phase II Efficacy Trial in Immunoglobulin A Nephropathy (IgAN) Patients: a renal disorder Up to 50% of IgAN patients with persistent proteinuria progress to kidney [...]
Canon Medical Informatics Selected by Leading U.S. Health System to Standardize 3D Processing Capabilities in the Cloud Using Vitrea Advanced Visualization Platform
02/12/2024
MINNETONKA, Minn., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Canon Medical Informatics, Inc. has been selected by a leading U.S. health system to standardize advanced imaging capabilities across 6 sites using the Vitrea [...]
Psychemedics Corporation Announces Reverse and Forward Stock Split
02/12/2024
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the [...]
Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
01/12/2024
Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational efficiency in ultrasound. The collaboration aims to facilitate [...]
Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia
01/12/2024
– Les données intermédiaires d’une étude de phase II portant sur le pétosemtamab administré à une dose de 1 500 mg en monothérapie continuent de démontrer une activité cliniquement significative dans le traitement de 2 [...]
Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024
01/12/2024
– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference call on Saturday, Dec. 7 at 9:00 a.m. ET to discuss full data set UTRECHT, The [...]
Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01/12/2024
December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading [...]
Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
01/12/2024
December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number [...]
At RSNA 2024, Konica Minolta Healthcare Introduces DR Solutions Designed to Optimize Workflows, Enhance Visualization and Manage Department Resources to Help Radiologists Build Intelligent Connections
01/12/2024
For the fourth consecutive year, studies evaluating the expanding clinical utility of Dynamic Digital Radiography are part of the RSNA Scientific Sessions WAYNE, N.J., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Konica Minolta [...]
RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety
01/12/2024
DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, [...]
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
30/11/2024
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company [...]
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29/11/2024
BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease [...]
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
29/11/2024
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today [...]
CorVel Announces Retirement of V. Gordon Clemons
29/11/2024
FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company’s Board of Directors (the “Board”) and as Chairman of [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/11/2024
SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
29/11/2024
PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received [...]

Pages